Companies: 48,687 Total Market Cap: 127305801127228.72

Fresenius SE & Co. KGaA

ETR-FRE

Healthcare Medical Care Facilities

Rank #765

Market Cap 26.85 B

Volume 1.89 M

Price 47.68

Change (%) 0.98%

Country or region

Germany

Fresenius SE & Co. KGaA's latest marketcap:

26.85 B

As of May 3, 2025, Fresenius SE & Co. KGaA's market capitalization has reached $26.85 B. According to our data, Fresenius SE & Co. KGaA is the 765th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	26.85 B
Revenue (ttm)	24.66 B
Net Income (ttm)	532.00 M
Shares Out	563.24 M
EPS (ttm)	0.94
Forward PE	12.88
Ex-Dividend Date	May 26, 2025
Earnings Date	May 7, 2025

Market Cap Chart

Data Updated: May 3, 2025

Fresenius SE & Co. KGaA's yearly market capitalization.

Fresenius SE & Co. KGaA has seen its market value grow from €21.09 B to €21.97 B since 2020, representing a total increase of 4.16% and an annual compound growth rate (CAGR) of 0.95%.

Date	Market Cap	Change (%)
April 17, 2025	€21.97 B	16.31%
December 30, 2024	€18.89 B	19.49%
December 29, 2023	€15.81 B	6.93%
December 30, 2022	€14.78 B	-25.21%
December 30, 2021	€19.77 B	-6.28%
December 30, 2020	€21.09 B

Company Profile

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA is a leading health care company specializing in products and services for chronically ill patients. Founded in 1912 and headquartered in Bad Homburg vor der Höhe, Germany, the company operates through four key segments.

Business Segments

Fresenius Medical Care: Focuses on chronic kidney failure patients, offering dialyzers, dialysis machines, disposable products, and dialysis-related services.
Fresenius Kabi: Provides critical care solutions, including enteral and parenteral nutrition products, medical technologies, infusion pumps, apheresis machines, and cell therapy devices.
Fresenius Helios: Delivers clinical and nursing care through healthcare facilities.
Fresenius Vamed: Offers hospital and healthcare facility management services, including operational oversight and patient care solutions.

Formerly known as Fresenius SE, the company rebranded as Fresenius SE & Co. KGaA in January 2011.

Frequently Asked Questions

As of May 3, 2025, Fresenius SE & Co. KGaA (including the parent company, if applicable) has an estimated market capitalization of $26.85 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Fresenius SE & Co. KGaA global market capitalization ranking is approximately 765 as of May 3, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Germany
Founded	1912
IPO Date	n/a
Employees	176,486
CEO	Michael Sen
Sector	Healthcare
Industry	Medical Care Facilities
Address	Else-Kröner-Str. 1 Bad Homburg vor der Höhe, 61352 Germany